The North America Endoscopic Retrograde Cholangiopancreatography Market is expected to witness market growth of 7.8% CAGR during the forecast period (2022-2028).
Several ongoing studies aimed at making these endoscopic retrograde cholangiopancreatography (ECRP) devices safer to use and more efficient, as well as increased government financing for R&D, along with rising awareness of endoscopic retrograde cholangiopancreatography (ECRP) devices with their growing availability could help drive the Market growth., is projected to drive Market expansion.
For the diagnosis and treatment of pancreatobiliary system problems, endoscopic retrograde cholangiopancreatography (ERCP) equipment typically uses an integration of fluoroscopic imaging and luminal endoscopy. Percutaneous transhepatic cholangiography is a therapeutic procedure for examining the biliary channel anatomy.
North America Endoscopic Retrograde Cholangiopancreatography Market growth is attributed to extensive diagnostic imaging research and the rapid establishment of technologically advanced ERCP tools such as sphincterotomes in the region.
Increased support from regional governments for healthcare along with the presence of important firms such as Hobbs Medical Inc. in the region is encouraging Market players to bring more innovations and enhancements in Endoscopic Retrograde Cholangiopancreatography.
Due to factors such as an increase in the number of surgeries for gallbladder disease, an increase in the prevalence rate of pancreatic diseases, and high healthcare expenditure across the United States, Canada, and Mexico.
Moreover, the adoption of endoscopic retrograde cholangiopancreatography is increasing across the region due to its well-established healthcare industry and rising incidence of Acute Pancreatitis. The United States owns the majority of the Market in the North American region due to growing healthcare spending, the development of novel solutions, and population awareness.
The US Market dominated the North America Others Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $38.2 million by 2028. The Canada Market is poised to grow at a CAGR of 13.4% during (2022-2028). Additionally, The Mexico Market is expected to witness a CAGR of 13.4% during (2022-2028).
Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.
By Procedure
By Country
Several ongoing studies aimed at making these endoscopic retrograde cholangiopancreatography (ECRP) devices safer to use and more efficient, as well as increased government financing for R&D, along with rising awareness of endoscopic retrograde cholangiopancreatography (ECRP) devices with their growing availability could help drive the Market growth., is projected to drive Market expansion.
For the diagnosis and treatment of pancreatobiliary system problems, endoscopic retrograde cholangiopancreatography (ERCP) equipment typically uses an integration of fluoroscopic imaging and luminal endoscopy. Percutaneous transhepatic cholangiography is a therapeutic procedure for examining the biliary channel anatomy.
North America Endoscopic Retrograde Cholangiopancreatography Market growth is attributed to extensive diagnostic imaging research and the rapid establishment of technologically advanced ERCP tools such as sphincterotomes in the region.
Increased support from regional governments for healthcare along with the presence of important firms such as Hobbs Medical Inc. in the region is encouraging Market players to bring more innovations and enhancements in Endoscopic Retrograde Cholangiopancreatography.
Due to factors such as an increase in the number of surgeries for gallbladder disease, an increase in the prevalence rate of pancreatic diseases, and high healthcare expenditure across the United States, Canada, and Mexico.
Moreover, the adoption of endoscopic retrograde cholangiopancreatography is increasing across the region due to its well-established healthcare industry and rising incidence of Acute Pancreatitis. The United States owns the majority of the Market in the North American region due to growing healthcare spending, the development of novel solutions, and population awareness.
The US Market dominated the North America Others Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $38.2 million by 2028. The Canada Market is poised to grow at a CAGR of 13.4% during (2022-2028). Additionally, The Mexico Market is expected to witness a CAGR of 13.4% during (2022-2028).
Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.
Scope of the Study
Market Segments Covered in the Report:
By Procedure
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dialatation
- Pancreatic Sphincterotomy
- Pancreatic Duct Stenting & Dilation
- Endotherapy Devices
- Stents & Sphincterotomes
- Catheters
- Lithotripter
- Cannulas
- Forceps
- Snares
- Guiding Wires
- Balloons
- Others
- Endoscopes
- Visualization Systems
- Energy Devices
- Others
- Hospitals
- Ambulatory Surgery Centres & Clinics
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Olympus Corporation
- Fujifilm Holdings Corporation
- Ambu A/S
- Boston Scientific Corporation
- Steris PLC
- Johnson & Johnson
- Braun Melsungen AG
- ConMed Corporation
- Medtronic PLC
- Karl Storz SE & Co. KG
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Endoscopic Retrograde Cholangiopancreatography Market by Procedure
Chapter 5. North America Endoscopic Retrograde Cholangiopancreatography Market by Product
Chapter 6. North America Endoscopic Retrograde Cholangiopancreatography Market by End User
Chapter 7. North America Endoscopic Retrograde Cholangiopancreatography Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Olympus Corporation
- Fujifilm Holdings Corporation
- Ambu A/S
- Boston Scientific Corporation
- Steris PLC
- Johnson & Johnson
- B. Braun Melsungen AG
- ConMed Corporation
- Medtronic PLC
- Karl Storz SE & Co. KG
Methodology
LOADING...
